APO Research

APO RESEARCH · REPORT

Histone Methyltransferases

Selected research

Market Structure

Global Histone Methyltransferases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Histone Methyltransferases market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Histone Methyltransferases include Eisai Co., Ltd., Pfizer, Glaxosmithkline (Gsk), Sirtris, Sigma-Aldrich, Sequenom, Inc., Ribomed Biotechnologies, Inc., Reaction Biology Corp. and Rana Therapeutics Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Histone Methyltransferases market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Histone Methyltransferases and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Histone Methyltransferases sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Histone Methyltransferases market size, projected growth trends, production technologies, key applications, and end-use industries.

Histone Methyltransferases Segment by Company

Eisai Co., Ltd.

Pfizer

Glaxosmithkline (Gsk)

Sirtris

Sigma-Aldrich

Sequenom, Inc.

Ribomed Biotechnologies, Inc.

Reaction Biology Corp.

Rana Therapeutics Inc.

Prognosdx Health, Inc.

Pharmacyclics, Inc

Epizyme, Inc.

Epitherapeutics APS

Domainex

Constellation Pharmaceuticals

Cellcentric Ltd.

Histone Methyltransferases Segment by Type

EZ

RIZ

SET1

SET2

SMYD

SUV39

SUV4-20

Histone Methyltransferases Segment by Application

Breast Cancer

Liver Cancer

Lung Cancer

Others

Histone Methyltransferases Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Methyltransferases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Methyltransferases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Methyltransferases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Histone Methyltransferases market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Histone Methyltransferases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Histone Methyltransferases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Histone Methyltransferases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Histone Methyltransferases Industry Trends Table 2. Histone Methyltransferases Industry Drivers Table 3. Histone Methyltransferases Industry Opportunities and Challenges Table 4. Histone Methyltransferases Industry Restraints Table 5. Global Histone Methyltransferases Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Histone Methyltransferases Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Histone Methyltransferases Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Histone Methyltransferases Sales Market Share by Manufacturers Table 9. Global Histone Methyltransferases Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Histone Methyltransferases Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Histone Methyltransferases Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Histone Methyltransferases Manufacturers, Product Type & Application Table 13. Global Histone Methyltransferases Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Histone Methyltransferases by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of EZ Table 17. Major Manufacturers of RIZ Table 18. Major Manufacturers of SET1 Table 19. Major Manufacturers of SET2 Table 20. Major Manufacturers of SMYD Table 21. Major Manufacturers of SUV39 Table 22. Major Manufacturers of SUV4-20 Table 23. Global Histone Methyltransferases Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Histone Methyltransferases Sales by Type (2021-2026) & (W Units) Table 25. Global Histone Methyltransferases Sales by Type (2027-2032) & (W Units) Table 26. Global Histone Methyltransferases Sales Market Share by Type (2021-2026) Table 27. Global Histone Methyltransferases Sales Market Share by Type (2027-2032) Table 28. Global Histone Methyltransferases Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 29. Global Histone Methyltransferases Revenue by Type (2021-2026) & (W Units) Table 30. Global Histone Methyltransferases Revenue by Type (2027-2032) & (W Units) Table 31. Global Histone Methyltransferases Revenue Market Share by Type (2021-2026) Table 32. Global Histone Methyltransferases Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Breast Cancer Table 34. Major Manufacturers of Liver Cancer Table 35. Major Manufacturers of Lung Cancer Table 36. Major Manufacturers of Others Table 37. Global Histone Methyltransferases Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Histone Methyltransferases Sales by Application (2021-2026) & (W Units) Table 39. Global Histone Methyltransferases Sales by Application (2027-2032) & (W Units) Table 40. Global Histone Methyltransferases Sales Market Share by Application (2021-2026) Table 41. Global Histone Methyltransferases Sales Market Share by Application (2027-2032) Table 42. Global Histone Methyltransferases Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 43. Global Histone Methyltransferases Revenue by Application (2021-2026) & (W Units) Table 44. Global Histone Methyltransferases Revenue by Application (2027-2032) & (W Units) Table 45. Global Histone Methyltransferases Revenue Market Share by Application (2021-2026) Table 46. Global Histone Methyltransferases Revenue Market Share by Application (2027-2032) Table 47. Global Histone Methyltransferases Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global Histone Methyltransferases Sales by Region (2021-2026) & (W Units) Table 49. Global Histone Methyltransferases Sales Market Share by Region (2021-2026) Table 50. Global Histone Methyltransferases Sales Forecasted by Region (2027-2032) & (W Units) Table 51. Global Histone Methyltransferases Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. North America Histone Methyltransferases Sales by Country (2021-2026) & (W Units) Table 54. North America Histone Methyltransferases Sales by Country (2027-2032) & (W Units) Table 55. Europe Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Europe Histone Methyltransferases Sales by Country (2021-2026) & (W Units) Table 57. Europe Histone Methyltransferases Sales by Country (2027-2032) & (W Units) Table 58. Asia Pacific Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. Asia Pacific Histone Methyltransferases Sales by Country (2021-2026) & (W Units) Table 60. Asia Pacific Histone Methyltransferases Sales by Country (2027-2032) & (W Units) Table 61. South America, Middle East and Africa Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 62. South America, Middle East and Africa Histone Methyltransferases Sales by Country (2021-2026) & (W Units) Table 63. South America, Middle East and Africa Histone Methyltransferases Sales by Country (2027-2032) & (W Units) Table 64. Global Histone Methyltransferases Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Histone Methyltransferases Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Histone Methyltransferases Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Histone Methyltransferases Revenue Market Share by Region (2021-2026) Table 68. Global Histone Methyltransferases Revenue Market Share by Region (2027-2032) Table 69. Eisai Co., Ltd. Company Information Table 70. Eisai Co., Ltd. Business Overview Table 71. Eisai Co., Ltd. Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Eisai Co., Ltd. Histone Methyltransferases Product Portfolio Table 73. Eisai Co., Ltd. Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Histone Methyltransferases Product Portfolio Table 78. Pfizer Recent Development Table 79. Glaxosmithkline (Gsk) Company Information Table 80. Glaxosmithkline (Gsk) Business Overview Table 81. Glaxosmithkline (Gsk) Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Glaxosmithkline (Gsk) Histone Methyltransferases Product Portfolio Table 83. Glaxosmithkline (Gsk) Recent Development Table 84. Sirtris Company Information Table 85. Sirtris Business Overview Table 86. Sirtris Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sirtris Histone Methyltransferases Product Portfolio Table 88. Sirtris Recent Development Table 89. Sigma-Aldrich Company Information Table 90. Sigma-Aldrich Business Overview Table 91. Sigma-Aldrich Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Sigma-Aldrich Histone Methyltransferases Product Portfolio Table 93. Sigma-Aldrich Recent Development Table 94. Sequenom, Inc. Company Information Table 95. Sequenom, Inc. Business Overview Table 96. Sequenom, Inc. Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Sequenom, Inc. Histone Methyltransferases Product Portfolio Table 98. Sequenom, Inc. Recent Development Table 99. Ribomed Biotechnologies, Inc. Company Information Table 100. Ribomed Biotechnologies, Inc. Business Overview Table 101. Ribomed Biotechnologies, Inc. Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Ribomed Biotechnologies, Inc. Histone Methyltransferases Product Portfolio Table 103. Ribomed Biotechnologies, Inc. Recent Development Table 104. Reaction Biology Corp. Company Information Table 105. Reaction Biology Corp. Business Overview Table 106. Reaction Biology Corp. Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Reaction Biology Corp. Histone Methyltransferases Product Portfolio Table 108. Reaction Biology Corp. Recent Development Table 109. Rana Therapeutics Inc. Company Information Table 110. Rana Therapeutics Inc. Business Overview Table 111. Rana Therapeutics Inc. Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Rana Therapeutics Inc. Histone Methyltransferases Product Portfolio Table 113. Rana Therapeutics Inc. Recent Development Table 114. Prognosdx Health, Inc. Company Information Table 115. Prognosdx Health, Inc. Business Overview Table 116. Prognosdx Health, Inc. Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Prognosdx Health, Inc. Histone Methyltransferases Product Portfolio Table 118. Prognosdx Health, Inc. Recent Development Table 119. Pharmacyclics, Inc Company Information Table 120. Pharmacyclics, Inc Business Overview Table 121. Pharmacyclics, Inc Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Pharmacyclics, Inc Histone Methyltransferases Product Portfolio Table 123. Pharmacyclics, Inc Recent Development Table 124. Epizyme, Inc. Company Information Table 125. Epizyme, Inc. Business Overview Table 126. Epizyme, Inc. Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Epizyme, Inc. Histone Methyltransferases Product Portfolio Table 128. Epizyme, Inc. Recent Development Table 129. Epitherapeutics APS Company Information Table 130. Epitherapeutics APS Business Overview Table 131. Epitherapeutics APS Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Epitherapeutics APS Histone Methyltransferases Product Portfolio Table 133. Epitherapeutics APS Recent Development Table 134. Domainex Company Information Table 135. Domainex Business Overview Table 136. Domainex Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Domainex Histone Methyltransferases Product Portfolio Table 138. Domainex Recent Development Table 139. Constellation Pharmaceuticals Company Information Table 140. Constellation Pharmaceuticals Business Overview Table 141. Constellation Pharmaceuticals Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Constellation Pharmaceuticals Histone Methyltransferases Product Portfolio Table 143. Constellation Pharmaceuticals Recent Development Table 144. Cellcentric Ltd. Company Information Table 145. Cellcentric Ltd. Business Overview Table 146. Cellcentric Ltd. Histone Methyltransferases Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Cellcentric Ltd. Histone Methyltransferases Product Portfolio Table 148. Cellcentric Ltd. Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Histone Methyltransferases Distributors List Table 152. Histone Methyltransferases Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Histone Methyltransferases Product Image Figure 2. Global Histone Methyltransferases Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Methyltransferases Market Size (2021-2032) & (US$ Million) Figure 4. Global Histone Methyltransferases Sales (2021-2032) & (W Units) Figure 5. Global Histone Methyltransferases Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Histone Methyltransferases Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. EZ Image Figure 9. RIZ Image Figure 10. SET1 Image Figure 11. SET2 Image Figure 12. SMYD Image Figure 13. SUV39 Image Figure 14. SUV4-20 Image Figure 15. Global Histone Methyltransferases Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Histone Methyltransferases Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Histone Methyltransferases Sales Market Share by Type (2021-2032) Figure 18. Global Histone Methyltransferases Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 19. Global Histone Methyltransferases Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Histone Methyltransferases Revenue Market Share by Type (2021-2032) Figure 21. Breast Cancer Image Figure 22. Liver Cancer Image Figure 23. Lung Cancer Image Figure 24. Others Image Figure 25. Global Histone Methyltransferases Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Histone Methyltransferases Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Histone Methyltransferases Sales Market Share by Application (2021-2032) Figure 28. Global Histone Methyltransferases Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 29. Global Histone Methyltransferases Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Histone Methyltransferases Revenue Market Share by Application (2021-2032) Figure 31. North America Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 32. North America Histone Methyltransferases Sales Market Share by Country (2021-2032) Figure 33. U.S. Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Canada Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Mexico Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Europe Histone Methyltransferases Sales Market Share by Country (2021-2032) Figure 38. Germany Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 39. France Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 40. U.K. Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Italy Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Netherlands Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Asia Pacific Histone Methyltransferases Sales Market Share by Country (2021-2032) Figure 45. China Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Japan Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Korea Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Southeast Asia Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 49. India Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Australia Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 52. South America, Middle East and Africa Histone Methyltransferases Sales Market Share by Country (2021-2032) Figure 53. Brazil Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 54. South Africa Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Saudi Arabia Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Turkey Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Argentina Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 58. UAE Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Egypt Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Chile Histone Methyltransferases Sales and Growth Rate (2021-2032) & (W Units) Figure 61. Global Histone Methyltransferases Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Histone Methyltransferases Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Histone Methyltransferases Revenue (2021-2032) & (US$ Million) Figure 64. North America Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Histone Methyltransferases Revenue (2021-2032) & (US$ Million) Figure 66. Europe Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Histone Methyltransferases Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Histone Methyltransferases Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Histone Methyltransferases Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Histone Methyltransferases Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • EZ
  • RIZ
  • SET1
  • SET2
  • SMYD
  • SUV39
  • SUV4-20
Applications
  • Breast Cancer
  • Liver Cancer
  • Lung Cancer
  • Others
Companies covered
  • Eisai Co., Ltd.
  • Pfizer
  • Glaxosmithkline (Gsk)
  • Sirtris
  • Sigma-Aldrich
  • Sequenom, Inc.
  • Ribomed Biotechnologies, Inc.
  • Reaction Biology Corp.
  • Rana Therapeutics Inc.
  • Prognosdx Health, Inc.
  • Pharmacyclics, Inc
  • Epizyme, Inc.
  • Epitherapeutics APS
  • Domainex
  • Constellation Pharmaceuticals
  • Cellcentric Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Histone Methyltransferases Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Histone Methyltransferases Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Histone Methyltransferases Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Histone Methyltransferases Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Histone Methyltransferases Market Dynamics
  1. 2.1 Histone Methyltransferases Industry Trends
  2. 2.2 Histone Methyltransferases Industry Drivers
  3. 2.3 Histone Methyltransferases Industry Opportunities and Challenges
  4. 2.4 Histone Methyltransferases Industry Restraints
3 Histone Methyltransferases Market by Manufacturers
  1. 3.1 Global Histone Methyltransferases Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Histone Methyltransferases Sales by Manufacturers (2021-2026)
  3. 3.3 Global Histone Methyltransferases Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Histone Methyltransferases Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Histone Methyltransferases Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Histone Methyltransferases Manufacturers, Product Type & Application
  7. 3.7 Global Histone Methyltransferases Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Histone Methyltransferases Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Histone Methyltransferases Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Histone Methyltransferases Tier 1, Tier 2, and Tier 3
4 Histone Methyltransferases Market by Type
  1. 4.1 Histone Methyltransferases Type Introduction
  2. 4.1.1 EZ
  3. 4.1.2 RIZ
  4. 4.1.3 SET1
  5. 4.1.4 SET2
  6. 4.1.5 SMYD
  7. 4.1.6 SUV39
  8. 4.1.7 SUV4-20
  9. 4.2 Global Histone Methyltransferases Sales by Type
  10. 4.2.1 Global Histone Methyltransferases Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Histone Methyltransferases Sales by Type (2021-2032)
  12. 4.2.3 Global Histone Methyltransferases Sales Market Share by Type (2021-2032)
  13. 4.3 Global Histone Methyltransferases Revenue by Type
  14. 4.3.1 Global Histone Methyltransferases Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Histone Methyltransferases Revenue by Type (2021-2032)
  16. 4.3.3 Global Histone Methyltransferases Revenue Market Share by Type (2021-2032)
5 Histone Methyltransferases Market by Application
  1. 5.1 Histone Methyltransferases Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Liver Cancer
  4. 5.1.3 Lung Cancer
  5. 5.1.4 Others
  6. 5.2 Global Histone Methyltransferases Sales by Application
  7. 5.2.1 Global Histone Methyltransferases Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Histone Methyltransferases Sales by Application (2021-2032)
  9. 5.2.3 Global Histone Methyltransferases Sales Market Share by Application (2021-2032)
  10. 5.3 Global Histone Methyltransferases Revenue by Application
  11. 5.3.1 Global Histone Methyltransferases Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Histone Methyltransferases Revenue by Application (2021-2032)
  13. 5.3.3 Global Histone Methyltransferases Revenue Market Share by Application (2021-2032)
6 Global Histone Methyltransferases Sales by Region
  1. 6.1 Global Histone Methyltransferases Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Histone Methyltransferases Sales by Region (2021-2032)
  3. 6.2.1 Global Histone Methyltransferases Sales by Region (2021-2026)
  4. 6.2.2 Global Histone Methyltransferases Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Histone Methyltransferases Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Histone Methyltransferases Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Histone Methyltransferases Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Histone Methyltransferases Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Histone Methyltransferases Revenue by Region
  1. 7.1 Global Histone Methyltransferases Revenue by Region
  2. 7.1.1 Global Histone Methyltransferases Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Histone Methyltransferases Revenue by Region (2021-2026)
  4. 7.1.3 Global Histone Methyltransferases Revenue by Region (2027-2032)
  5. 7.1.4 Global Histone Methyltransferases Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Histone Methyltransferases Revenue (2021-2032)
  8. 7.2.2 North America Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Histone Methyltransferases Revenue (2021-2032)
  11. 7.3.2 Europe Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Histone Methyltransferases Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Histone Methyltransferases Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai Co., Ltd.
  2. 8.1.1 Eisai Co., Ltd. Company Information
  3. 8.1.2 Eisai Co., Ltd. Business Overview
  4. 8.1.3 Eisai Co., Ltd. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Co., Ltd. Histone Methyltransferases Product Portfolio
  6. 8.1.5 Eisai Co., Ltd. Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Histone Methyltransferases Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Glaxosmithkline (Gsk)
  14. 8.3.1 Glaxosmithkline (Gsk) Company Information
  15. 8.3.2 Glaxosmithkline (Gsk) Business Overview
  16. 8.3.3 Glaxosmithkline (Gsk) Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glaxosmithkline (Gsk) Histone Methyltransferases Product Portfolio
  18. 8.3.5 Glaxosmithkline (Gsk) Recent Developments
  19. 8.4 Sirtris
  20. 8.4.1 Sirtris Company Information
  21. 8.4.2 Sirtris Business Overview
  22. 8.4.3 Sirtris Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sirtris Histone Methyltransferases Product Portfolio
  24. 8.4.5 Sirtris Recent Developments
  25. 8.5 Sigma-Aldrich
  26. 8.5.1 Sigma-Aldrich Company Information
  27. 8.5.2 Sigma-Aldrich Business Overview
  28. 8.5.3 Sigma-Aldrich Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sigma-Aldrich Histone Methyltransferases Product Portfolio
  30. 8.5.5 Sigma-Aldrich Recent Developments
  31. 8.6 Sequenom, Inc.
  32. 8.6.1 Sequenom, Inc. Company Information
  33. 8.6.2 Sequenom, Inc. Business Overview
  34. 8.6.3 Sequenom, Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sequenom, Inc. Histone Methyltransferases Product Portfolio
  36. 8.6.5 Sequenom, Inc. Recent Developments
  37. 8.7 Ribomed Biotechnologies, Inc.
  38. 8.7.1 Ribomed Biotechnologies, Inc. Company Information
  39. 8.7.2 Ribomed Biotechnologies, Inc. Business Overview
  40. 8.7.3 Ribomed Biotechnologies, Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ribomed Biotechnologies, Inc. Histone Methyltransferases Product Portfolio
  42. 8.7.5 Ribomed Biotechnologies, Inc. Recent Developments
  43. 8.8 Reaction Biology Corp.
  44. 8.8.1 Reaction Biology Corp. Company Information
  45. 8.8.2 Reaction Biology Corp. Business Overview
  46. 8.8.3 Reaction Biology Corp. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Reaction Biology Corp. Histone Methyltransferases Product Portfolio
  48. 8.8.5 Reaction Biology Corp. Recent Developments
  49. 8.9 Rana Therapeutics Inc.
  50. 8.9.1 Rana Therapeutics Inc. Company Information
  51. 8.9.2 Rana Therapeutics Inc. Business Overview
  52. 8.9.3 Rana Therapeutics Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Rana Therapeutics Inc. Histone Methyltransferases Product Portfolio
  54. 8.9.5 Rana Therapeutics Inc. Recent Developments
  55. 8.10 Prognosdx Health, Inc.
  56. 8.10.1 Prognosdx Health, Inc. Company Information
  57. 8.10.2 Prognosdx Health, Inc. Business Overview
  58. 8.10.3 Prognosdx Health, Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Prognosdx Health, Inc. Histone Methyltransferases Product Portfolio
  60. 8.10.5 Prognosdx Health, Inc. Recent Developments
  61. 8.11 Pharmacyclics, Inc
  62. 8.11.1 Pharmacyclics, Inc Company Information
  63. 8.11.2 Pharmacyclics, Inc Business Overview
  64. 8.11.3 Pharmacyclics, Inc Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pharmacyclics, Inc Histone Methyltransferases Product Portfolio
  66. 8.11.5 Pharmacyclics, Inc Recent Developments
  67. 8.12 Epizyme, Inc.
  68. 8.12.1 Epizyme, Inc. Company Information
  69. 8.12.2 Epizyme, Inc. Business Overview
  70. 8.12.3 Epizyme, Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Epizyme, Inc. Histone Methyltransferases Product Portfolio
  72. 8.12.5 Epizyme, Inc. Recent Developments
  73. 8.13 Epitherapeutics APS
  74. 8.13.1 Epitherapeutics APS Company Information
  75. 8.13.2 Epitherapeutics APS Business Overview
  76. 8.13.3 Epitherapeutics APS Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Epitherapeutics APS Histone Methyltransferases Product Portfolio
  78. 8.13.5 Epitherapeutics APS Recent Developments
  79. 8.14 Domainex
  80. 8.14.1 Domainex Company Information
  81. 8.14.2 Domainex Business Overview
  82. 8.14.3 Domainex Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Domainex Histone Methyltransferases Product Portfolio
  84. 8.14.5 Domainex Recent Developments
  85. 8.15 Constellation Pharmaceuticals
  86. 8.15.1 Constellation Pharmaceuticals Company Information
  87. 8.15.2 Constellation Pharmaceuticals Business Overview
  88. 8.15.3 Constellation Pharmaceuticals Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Constellation Pharmaceuticals Histone Methyltransferases Product Portfolio
  90. 8.15.5 Constellation Pharmaceuticals Recent Developments
  91. 8.16 Cellcentric Ltd.
  92. 8.16.1 Cellcentric Ltd. Company Information
  93. 8.16.2 Cellcentric Ltd. Business Overview
  94. 8.16.3 Cellcentric Ltd. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Cellcentric Ltd. Histone Methyltransferases Product Portfolio
  96. 8.16.5 Cellcentric Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Histone Methyltransferases Value Chain Analysis
  2. 9.1.1 Histone Methyltransferases Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Histone Methyltransferases Production Mode & Process
  6. 9.2 Histone Methyltransferases Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Histone Methyltransferases Distributors
  9. 9.2.3 Histone Methyltransferases Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research